FDA 510(k) Labeling & IFU Completeness Tool

Use this page as a working utility before you file. Score your current labeling package, identify likely reviewer friction points, and turn open issues into an executable remediation plan for your 510(k).

What This Tool Is Designed To Do

This is a planning and quality-control tool for drafting stronger 510(k) labeling files. It does not replace legal or regulatory review. It helps teams make faster decisions on where to focus effort first:

  • check_circleEstimate labeling/IFU deficiency risk based on cross-document consistency and claim support.
  • check_circlePrioritize high-impact fixes that directly improve reviewer readability and traceability.
  • check_circleMap each labeling claim to objective evidence so the submission package is easier to defend.

Interactive Labeling Readiness Estimator

Set each field to the status of your current draft package. The estimator weights issues by expected reviewer impact.

Run the estimator to view your readiness score and priority fixes.

Scoring is directional and intended for drafting triage, not formal regulatory determination.

Claim-to-Evidence Matrix Template (Use Before eSTAR Build)

Populate this matrix in your internal review meeting. Missing links between claims and objective evidence are one of the most avoidable causes of back-and-forth during review preparation.

Labeling Claim Type Evidence You Should Link Frequent Gaps Practical Fix
Indications for Use / Intended Use Exact text alignment across forms, cover letter, IFU, and summary sections Near-matching language with hidden scope differences Lock one source-of-truth indication statement and propagate verbatim
Warnings / Precautions Risk analysis outputs, hazard controls, residual risk rationale Warnings present in risk file but absent or softened in IFU Run line-by-line reconciliation from risk file to IFU section headers
Sterility / Reprocessing Validation protocols, acceptance criteria, test reports, shelf-life support Marketing-like claims that exceed available test scope Constrain claim language to validated conditions and limits
Performance Claims Bench testing, software verification, biocompatibility/electrical evidence as applicable Claims not traceable to a specific report section Add evidence locator references in your internal labeling register
UDI / Device Identification Draft label examples, implementation approach, packaging hierarchy logic UDI planning deferred too late, creating relabeling risk Align draft labeling outputs with final commercial label architecture early
User Workflow Instructions Human factors outputs, usability findings, operator training assumptions Critical steps omitted or buried in dense narrative Rewrite into clear sequence blocks tied to user role/context

510(k) Labeling Review Checklist for Team Gate Reviews

Consistency Gate

  • task_altIndications and intended use are identical everywhere they appear.
  • task_altDevice naming and model hierarchy are consistent across labels, IFU, and test references.
  • task_altRisk-control language in IFU matches risk management outputs.

Evidence Gate

  • task_altEvery meaningful labeling claim maps to objective evidence.
  • task_altClaims are bounded to tested conditions and limitations.
  • task_altSubmission artifacts include stable cross-reference points for reviewers.

Usability Gate

  • task_altIFU workflow can be followed without hidden assumptions.
  • task_altWarnings, contraindications, and user limitations are prominent and unambiguous.
  • task_altSymbols and abbreviations are defined in one visible location.

Turn Labeling Edits Into a Reviewer-Ready 510(k) Package

Cruxi links your IFU, labeling claims, evidence references, and submission sections so reviewers can follow the logic quickly and your team can avoid late-cycle rewrites.

Build a Stronger 510(k) Submission

Regulatory Context and Citations

This page is based on public FDA and eCFR source material that teams commonly use when preparing labeling content and review packets.

  1. 21 CFR Part 801 - Labeling (eCFR)
  2. 21 CFR Part 830 - Unique Device Identification (eCFR)
  3. 21 CFR Part 807 Subpart E - Premarket Notification Procedures (eCFR)
  4. FDA Medical Device Labeling Overview
  5. FDA UDI System Resources
  6. FDA 510(k) Program Resources

FAQ

What labeling files are most likely to trigger a 510(k) deficiency?

In practice, issues often come from cross-document mismatches, incomplete warnings/contraindications, vague workflow instructions, and claims that are not clearly linked to objective evidence.

Does UDI labeling need to be shown in a 510(k)?

Teams generally reduce risk by aligning draft submission labeling with the UDI approach they plan to implement commercially, so identification elements and packaging logic do not need late-cycle rework.

How should I connect labeling claims to verification evidence?

Create and maintain a claim-to-evidence matrix with direct references to reports, acceptance criteria, and pass/fail outcomes. This makes internal QC and reviewer navigation significantly easier.